Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
08/2014
08/13/2014CN103976984A 罗勒烯在制备抗抑郁药物中的应用 Ocimene antidepressant in the preparation of a medicament
08/13/2014CN103976982A 一种包载重组人生长激素缓释药物微囊 For packet contained recombinant human growth hormone drug release microcapsules
08/13/2014CN103976972A 酒石酸唑吡坦口服脉冲控释给药系统及其制备方法 Zolpidem tartrate oral pulsatile release drug delivery system and its preparation method
08/13/2014CN103976971A 盐酸度洛西汀控释片及其制备方法 Duloxetine hydrochloride controlled release tablets and its preparation method
08/13/2014CN103976967A 一种银杏内酯舌下片及其制备方法 Ginkgo lactones sublingual tablets and its preparation method
08/13/2014CN103976957A 一种20(s)-原人参二醇微球及其制备方法和应用 One kind of 20 (s) - protopanaxadiol microsphere and its preparation method and application
08/13/2014CN103976219A 一种酒酿营养物或酿酒营养产物二步发酵制备法及用途 One kind of wine fermented nutrients or nutrient product two-step fermentation preparation method and uses
08/13/2014CN103975959A 一种安神助眠型蚊香及其制备方法 A sleep aids mosquito coils and preparation method nerves
08/13/2014CN103356766B 一种改善睡眠质量的中药 An improved quality of sleep medicine
08/13/2014CN103316285B 戒毒中药 Rehabilitation medicine
08/13/2014CN103316016B 一种含有卡马西平的药物组合物及其应用 Carbamazepine containing pharmaceutical composition and its application
08/13/2014CN103304522B 一种具有抑制神经炎症活性的化合物及其制备方法与应用 A compound and its preparation method and application of neural inhibition of inflammatory activity has
08/13/2014CN103263549B 一种治疗糖尿病足的中药熏洗剂 A method of treating diabetic foot lotion smoked medicine
08/13/2014CN103239607B 一种治疗神经衰弱引起健忘症的中药制剂 A method of treating neurasthenia caused amnesia Chinese medicine
08/13/2014CN103232914B 一种补血养心酒及其制备方法 A nourishing the heart and blood wine and its preparation method
08/13/2014CN103211917B 一种鹿角盘酒及其制备方法 One kind of wine and its preparation method antlers disc
08/13/2014CN103193742B 苍耳亭衍生物及其药物用途 Cocklebur Pavilion derivatives and pharmaceutical use
08/13/2014CN103142916B 一种预防和治疗老年性痴呆病的药物 A method of preventing and treating senile dementia drugs
08/13/2014CN103127005B 一种多巴胺脑靶向纳米粒的制备方法 A dopamine brain targeting nanoparticles prepared
08/13/2014CN103083315B 一种中药成分组合物及其用途 Chinese medicinal ingredients of the composition and its use
08/13/2014CN102935220B 一种改善人体亚健康状况的药物 A method for improving the situation of human sub-drug
08/13/2014CN102883733B Age生成抑制剂 Age generation inhibitors
08/13/2014CN102813768B 一种胆南星的生产方法及装置 A Southern Star production methods and apparatus for bile
08/13/2014CN102796121B 3-芳基-7H-噻唑并[3,2-b]-1,2,4-三嗪-7-酮类衍生物及其应用 3-aryl -7H- thiazolo [3,2-b] -1,2,4- triazin-7-one derivatives and their Applications
08/13/2014CN102772704B 老年病药物 Geriatrics drugs
08/13/2014CN102716207B 一种治疗三叉神经痛的药物及其制备方法 A drug treatment of trigeminal neuralgia and its preparation method
08/13/2014CN102697844B 一种闻剂中草药 One kind of smell agent herbs
08/13/2014CN102675228B 一种治疗缺血性脑损伤中风及其后遗症的药物与制备方法 An ischemic stroke, brain injury and its sequelae of drug treatment and preparation methods
08/13/2014CN102603575B 大精酸共晶物、其制备方法、纯化方法及其在制备治疗糖尿病并发症药物中的应用 Big fine acid eutectic composition, its preparation and purification method and its application in the manufacture of a medicament for the treatment of diabetic complications
08/13/2014CN102579441B 真菌环氧二烯烟酸类衍生物在制备促炎介质抑制剂的应用 Fungal epoxy diene acid derivatives used in the preparation of inhibitors of proinflammatory mediators
08/13/2014CN102344442B 一种枸橼酸坦度螺酮化合物的晶型及其制备方法和用途 One kind of compound citrate tandospirone crystalline form and its preparation method and use
08/13/2014CN102325778B 盐酸纳美芬二水合物 Nalmefene hydrochloride dihydrate
08/13/2014CN102260246B 低毒性cb1受体抑制剂、其制备方法及其在制备戒毒、减肥或治疗糖尿病药物中的应用 Low toxicity cb1 receptor inhibitors, their preparation and their treatment in the preparation, diet or treatment of diabetes drug application
08/13/2014CN102083442B 抗氧化剂炎症调节剂:在c-17具有氨基和其它修饰的齐墩果酸衍生物 Oleanolic acid derivatives having an amino group and other modifications in the c-17: Antioxidant Inflammation Modulators
08/13/2014CN102015636B 作为组胺h3受体拮抗剂的氮杂环丁烷类和环丁烷类化合物 Azetidine as histamine h3 class and cyclobutane receptor antagonist compounds
08/13/2014CN101987198B 药物组合物 The pharmaceutical composition of
08/13/2014CN101679219B 合成离子通道 Synthetic ion channels
08/13/2014CN101585778B 一种普瑞巴林制备方法 One kind of pregabalin preparation
08/13/2014CN101160403B 转运化合物穿过血脑屏障的分子 Transporter molecule compound across the blood-brain barrier
08/12/2014US8802717 Methods of treating arthritic conditions using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline 1,3-dione
08/12/2014US8802706 Method for treating fibromyalgia
08/12/2014US8802088 Mixture of peptide-bound tryptophan and polypeptide-bound tryptophan
08/12/2014CA2707648C Isoxazolo-pyridine derivatives
08/12/2014CA2683941C Nitrogen-containing six-membered aromatic ring derivatives and pharmaceutical products containing the same
08/12/2014CA2665924C Piperidinylamino-pyridazines and their use as fast dissociating dopamine 2 receptor antagonists
08/12/2014CA2629312C Compositions and methods for treating cns disorders
08/12/2014CA2540681C Methods for altering mrna splicing and treating familial dysautonomia and other mechanistically related disorders
08/07/2014WO2014121062A1 Selective hdac3 inhibitors
08/07/2014WO2014120994A1 Rufinamide and derivatives and their use in modulating the gating process of human voltage-gated sodium channels
08/07/2014WO2014120885A1 Treatment of drug abuse by preventing gapdh nitrosylation
08/07/2014WO2014120815A1 Quinoline and quinazoline amides as modulators of sodium channels
08/07/2014WO2014120800A1 Spiro-lactam nmda receptor modulators and uses thereof
08/07/2014WO2014120789A1 Spiro-lactam nmda receptor modulators and uses thereof
08/07/2014WO2014120786A1 Spiro-lactam nmda receptor modulators and uses thereof
08/07/2014WO2014120784A1 Spiro-lactam nmda receptor modulators and uses thereof
08/07/2014WO2014120783A1 Spiro-lactam nmda receptor modulators and uses thereof
08/07/2014WO2014120658A1 Fused multicyclic 3-amino-5,6-dihydro-2h-1,4-thiazine derivatives and their use as beta-secretase inhibitors
08/07/2014WO2014120654A1 Benzoquinolone inhibitors of vmat2
08/07/2014WO2014120538A1 PPARγ AGONISTS FOR TREATMENT OF MULTIPLE SCLEROSIS
08/07/2014WO2014118307A1 Salt polymorph of thioxanthene-9-ylidene-1-methyl piperidine acid addition salts as antimigraine compounds
08/07/2014WO2014118133A1 Pyridine derivatives as soft rock inhibitors
08/07/2014WO2014118039A1 Radiolabeled compounds
08/07/2014WO2014117947A1 4-amino substituted condensed pyrimidine compounds as pde4 inhibitors
08/07/2014WO2014117919A1 Positive allosteric modulators of mglur3
08/07/2014WO2014117863A1 Salt polymorph of thioxanthene - 9 - ylidene - 1 - methyl piperidine acid addition salts as antimigraine compounds
08/07/2014WO2014117220A1 Anti-cd83 antibodies and use thereof
08/07/2014WO2014073946A3 Use of betalains and derivatives thereof for the production of a drug for the treatment, prevention, regulation and control of hepatopathies, diseases with inflammatory infiltrate, necrosis and for the modificaiton of lipid deposits
08/07/2014WO2013111013A8 Methods for treating alzheimer's disease by administering certain synthetic compounds
08/07/2014US20140221407 Use and application of a pharmaceutical composition containing a mixture of natural-origin heterocyclical guanidine, for cosmetology, wound healing, focal dystonia and muscular spasm- related clinical pathologies
08/07/2014US20140221388 Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders
08/07/2014US20140221381 Thienopyrimidine compounds and use thereof
08/07/2014US20140220676 Method and Medicament for Inhibiting the Expression of a Given Gene
08/07/2014US20140220590 Methods of using benzothiazole derivative compounds and compositions
08/07/2014US20140220113 Method and Medicament for Inhibiting the Expression of a Given Gene
08/07/2014US20140220109 Novel cochleate formulations
08/06/2014EP2762489A1 Glycosylated polypeptide and pharmaceutical composition containing same
08/06/2014EP2762466A1 Phenyl derivative
08/06/2014EP2762151A1 Exogenous opioid peptide-degrading enzyme
08/06/2014EP2762138A1 Pharmaceutical substance (variants) and compositions based thereon which exhibit modulatory activity with a commensurate effect
08/06/2014EP2762137A1 Use of myricetin or derivatives thereof as a cathepsin k inhibitor
08/06/2014EP2762136A1 Methods of stimulating cellular growth, synaptic remodeling and consolidation of long-term memory
08/06/2014EP2762135A1 Methods for reducing the risk of an adverse teriflunomide and rosuvastatin interaction in multiple sclerosis patients
08/06/2014EP2761019A1 Inhibitors of nox4 expression and/or nox4 function and their use in the prevention and treatment of nerve injury and/or neuropathic pain
08/06/2014EP2761002A1 Inhibition of microrna-134 for the treatment of seizure-related disorders and neurologic injuries
08/06/2014EP2760858A1 Uridine diphosphate derivatives, compositions and methods for treating neurodegenerative disorders
08/06/2014EP2760856A1 Selective nr2b antagonists
08/06/2014EP2760852A1 Improved process for the preparation of sulfamide derivatives
08/06/2014EP2760851A1 Process for the preparation of sulfamide derivatives
08/06/2014EP2760843A2 Selective nr2b antagonists
08/06/2014EP2760837A1 Substituted methanesulfonamide derivatives as vanilloid receptor ligands
08/06/2014EP2760836A1 Amine substituted methanesulfonamide derivatives as vanilloid receptor ligands
08/06/2014EP2760453A1 Macrocyclic lrrk2 kinase inhibitors
08/06/2014EP2760440A1 A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (cbdv) and cannabidiol (cbd)
08/06/2014CN103974951A 6-二氟甲基-5,6-二氢-2h-[1,4]噁嗪-3-胺衍生物 6-fluoro-5,6-dihydro -2h- [1,4] oxazin-3-amine derivative
08/06/2014CN103974947A 可用于体内成像的5ht1a拮抗剂 Can be used for in vivo imaging 5ht1a antagonist
08/06/2014CN103974944A 用作kv3抑制剂的乙内酰脲衍生物 The inhibitor used kv3 hydantoin derivative
08/06/2014CN103974940A 5-(3-氨基苯基)-5-烷基-5,6-二氢-2h-[1,4]噁嗪-3-胺衍生物 5- (3-aminophenyl) -5-alkyl-5,6-dihydro--2h- [1,4] oxazin-3-amine derivative
08/06/2014CN103974934A 使用sirt2调节剂的治疗方法 Methods of treatment using sirt2 modulators
08/06/2014CN103974714A 阿尔茨海默氏病的诊断和治疗方法 Alzheimer's disease diagnosis and treatment
08/06/2014CN103966309A 外周血细胞TRPC6mRNA水平用于早期预测/诊断老年性痴呆 Peripheral blood cells TRPC6mRNA level for early prediction / diagnosis of senile dementia
1 ... 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 ... 1833